v3.25.4
Condensed Consolidated Statements of Changes in Stockholder's Deficit - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Ending balance at Dec. 31, 2023 [1] $ 1,750 $ 9,323,403 $ (25,118,907) $ (15,793,754)
Ending balance (in shares) at Dec. 31, 2023 [1] 17,500,000      
Net income (loss)     (1,753,978) (1,753,978)
Ending balance at Mar. 31, 2024 [1] $ 1,750 9,323,403 (26,872,885) (17,547,732)
Ending balance (in shares) at Mar. 31, 2024 [1] 17,500,000      
Beginning balance at Dec. 31, 2023 [1] $ 1,750 9,323,403 (25,118,907) (15,793,754)
Beginning balance (in shares) at Dec. 31, 2023 [1] 17,500,000      
Net income (loss)       (3,316,557)
Ending balance at Sep. 30, 2024 [1] $ 1,750 9,323,403 (28,435,464) (19,110,311)
Ending balance (in shares) at Sep. 30, 2024 [1] 17,500,000      
Beginning balance at Dec. 31, 2023 [1] $ 1,750 9,323,403 (25,118,907) (15,793,754)
Beginning balance (in shares) at Dec. 31, 2023 [1] 17,500,000      
Ending balance at Dec. 31, 2024 [1] $ 1,750 9,323,403 (28,665,216) $ (19,340,063)
Ending balance (in shares) at Dec. 31, 2024 17,500,000 [1]     17,500,000
Beginning balance at Mar. 31, 2024 [1] $ 1,750 9,323,403 (26,872,885) $ (17,547,732)
Beginning balance (in shares) at Mar. 31, 2024 [1] 17,500,000      
Net income (loss)     (961,207) (961,207)
Ending balance at Jun. 30, 2024 [1] $ 1,750 9,323,403 (27,834,092) (18,508,939)
Ending balance (in shares) at Jun. 30, 2024 [1] 17,500,000      
Net income (loss)     (601,372) (601,372)
Ending balance at Sep. 30, 2024 [1] $ 1,750 9,323,403 (28,435,464) (19,110,311)
Ending balance (in shares) at Sep. 30, 2024 [1] 17,500,000      
Beginning balance at Dec. 31, 2024 [1] $ 1,750 9,323,403 (28,665,216) $ (19,340,063)
Beginning balance (in shares) at Dec. 31, 2024 17,500,000 [1]     17,500,000
Net income (loss)     (327,526) $ (327,526)
Ending balance at Mar. 31, 2025 [1] $ 1,750 9,323,403 (28,992,742) (19,667,589)
Ending balance (in shares) at Mar. 31, 2025 [1] 17,500,000      
Beginning balance at Dec. 31, 2024 [1] $ 1,750 9,323,403 (28,665,216) $ (19,340,063)
Beginning balance (in shares) at Dec. 31, 2024 17,500,000 [1]     17,500,000
Net income (loss)       $ (2,037,590)
Ending balance at Sep. 30, 2025 $ 2,706 29,054,337 (30,702,806) $ (1,645,763)
Ending balance (in shares) at Sep. 30, 2025 27,064,633     27,064,633
Beginning balance at Mar. 31, 2025 [1] $ 1,750 9,323,403 (28,992,742) $ (19,667,589)
Beginning balance (in shares) at Mar. 31, 2025 [1] 17,500,000      
Business combination with IRIS, net of transaction costs $ 11 190,379   190,390
Business combination with IRIS, net of transaction costs (in shares) 114,633      
Settlement of loans to Iris Acquisition Corp upon closing of the business combination   (4,443,500)   (4,443,500)
Issuance of common stock to Iris Acquisition Holdings, LLC $ 690 (690)    
Issuance of common stock to Iris Acquisition Holdings, LLC (in shares) 6,900,000      
Issuance of common stock in for PIPE investment $ 150 14,999,850   15,000,000
Issuance of common stock in for PIPE investment (in shares) 1,500,000      
Net income (loss)     113,287 113,287
Ending balance at Jun. 30, 2025 $ 2,601 20,069,442 (28,879,455) (8,807,412)
Ending balance (in shares) at Jun. 30, 2025 26,014,633      
Issuance of common stock to underwriter $ 70 7,244,930   7,245,000
Issuance of common stock to underwriter (In shares) 700,000      
Issuance of common stock in connection with the surrender of warrants $ 35 1,739,965   1,740,000
Issuance of common stock in connection with the surrender of warrants (in shares) 350,000      
Net income (loss)     (1,823,351) (1,823,351)
Ending balance at Sep. 30, 2025 $ 2,706 $ 29,054,337 $ (30,702,806) $ (1,645,763)
Ending balance (in shares) at Sep. 30, 2025 27,064,633     27,064,633
[1] Shares, preferred stock amount, common stock amount and additional paid - in capital data are presented on a retroactive basis to reflect the effects of the conversion and recapitalization as a result of the Business Combination consummated on April 30, 2025.